Lv1
50 积分 2023-08-03 加入
Enhanced efficiency of MHC class II tumor neoantigen vaccines with a novel CD4+ T-cell helper epitope
14天前
已完结
Immunogenic SARS-CoV2 Epitopes Defined by Mass Spectrometry
14天前
已关闭
Effective design of therapeutic nanovaccines based on tumor neoantigens
14天前
已完结
Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
14天前
已完结
Personalized mRNA Vaccine Immunogenic against PDAC
14天前
已完结
Engineered virus-hunter vaccine overcomes HBV immune tolerance
4个月前
已完结